Latest California Healthline Stories
Half the public believes the worst of the pandemic is yet to come, but most are prepared to continue to take measures to limit the spread of COVID-19 until vaccines are distributed.
Congress seems on the verge of finishing a long-delayed COVID-19 relief bill, which will reportedly include neither of the things each party wanted most — for Republicans, liability protections; for Democrats, funding for states and localities. That bill is likely to be tied to a package to fund the federal government for the rest of the fiscal year and, possibly, include a fix for “surprise” medical bills that patients receive when they inadvertently receive care outside their insurance network. Alice Miranda Ollstein of Politico, Rebecca Adams of CQ Roll Call and Mary Agnes Carey of KHN join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner talks to Elizabeth Mitchell, president and CEO of the Pacific Business Group on Health, about the future of employer-provided health insurance.
It’s no worse than the flu, and other deadly disinformation about the coronavirus
Host Dan Weissmann gives us an inside look at his family’s quest to pick health insurance for next year. COVID-19 makes it more complicated.
At least 181 public health leaders in 38 states have resigned, retired or been fired amid the turmoil of the pandemic. The departures come as backlash against public health is rising with threats to officials’ personal safety and legislative and legal efforts to strip their governmental public health powers.
Kent Thiry, the former CEO of dialysis giant DaVita, has clear ideas about how democracy should work. By backing ballot measures in Colorado, he’s shaping the power of voters in that state.
Even as the federal Food and Drug Administration engaged in intense deliberations ahead of Friday’s authorization of the nation’s first COVID vaccine, and days before the initial doses were to be released, hospitals have been grappling with how to distribute the first scarce shots. Their plans vary broadly.
What’s a 67-year-old to do when COVID-19 shuts down the volunteering gigs that were his personal fountain of youth?
Everyone — from toilet paper manufacturers to patient advocates — is lobbying state advisory boards, arguing their members are essential, vulnerable or both — and, thus, most deserving of an early vaccine.
Even as the Food and Drug Administration nears emergency authorization for the first vaccine to protect against COVID-19, Congress remains at loggerheads over a COVID relief bill that could also provide the funding to fully distribute the vaccines. Meanwhile, President-elect Joe Biden announced the first members of his health team. Joanne Kenen of Politico, Kimberly Leonard of Business Insider and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Michael Mackert of the University of Texas-Austin, an expert on communicating public health information.